Evaluating survival in aggressive variant prostate cancer patients undergoing PSMA radioligand therapy. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...

Association between prostate radiation therapy and survival among patients with metastatic prostate cancer by extent of disease burden. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Truqap with Zytiga and ADT improved radiographic progression-free survival in patients with PTEN-deficient prostate cancer compared to placebo. The CAPitello-281 trial involved 1,012 patients, showing ...

Immunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved in metastatic castrate-resistant prostate cancer (mCRPC). A study published ...

Researchers have characterised prostate cancer cell dynamics at a single-cell resolution across the timespan of the disease -- from its beginning to the point of androgen independence, where the ...

Figure 5. miR-377 transfection in prostate cancer cell lines can target MYC 3′UTR, degrade its mRNA, and affect apoptosis, cell cycle, migration, and cell ...

A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumours Unit of the Institut Català d'Oncologia (ICO) and the Germans Trias i Pujol Research ...

Cancer is very difficult to treat due to various components that therapies must address to effectively kill or lyse tumor cells. There are two general categories of cancer: blood or hematologic ...